The guideline makes a series of recommendations which are coded as to level of clinical confidence; these are either substantial (I), moderate (II), or on the basis of individual circumstances (III).

As with other medication, the guideline notes that the optimum time period on SSRIs is not known. When the medication is discontinued, the taper should occur over several weeks.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Dr. John Winkelman, MD, PhD, Chief of the Sleep Disorders Clinical Research Program in the Department of Psychiatry at ...

An updated evidence-based guideline aimed at helping clinicians and other health care providers manage patients with opioid ...

A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for ...

The trend in recent decades has been to ignore social psychiatry approaches that call out the mental health effects of broken ...

Welcome to the Seattle Children’s Psychiatric Advanced Practice Provider (APP) Fellowship! Our mission is to provide board certified Psychiatric Mental Health Nurse Practitioners and Physician ...

The American Academy of Sleep Medicine (AASM) released a clinical practice guideline (CPG) update in the Journal of Sleep Medicine about ... Neurology Advisor spoke to John W Winkelman, MD, PhD, a ...

The issue also includes an executive summary of the new American Psychiatric Association Practice Guideline for the Treatment of Patients with Borderline Personality Disorder. (Full guidelines ...